-
Mashup Score: 0Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis - 7 month(s) ago
It’s reassuring to see efficacy at the higher end of the spectrum and safety at the lower end, Muthiah Vaduganathan says.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Post-TAVR stroke is rare, but it can be fatal. A new study in Catheterization and Cardiovascular Interventions examined the issue in great detail, focusing on more than 2,700 patients treated over a two-year stretch.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 13Semaglutide Effects According to Ejection Fraction in Heart Failure with Preserved Ejection Fraction and Obesity: - 7 month(s) ago
ABSTRACT Background Many therapies for heart failure (HF) have shown differential impact across the spectrum of left ventricular ejection fraction (LVEF). Objectives In this prespecified analysis, …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
#HFSA2023 #JACC LBCT SimPub: In 529 pts w/ obesity-related #HFpEF, #semaglutide 2.4 mg improved HFpEF outcomes to a similar degree vs placebo across baseline #LVEF categories, supporting its use for obesity-related HFpEF regardless of LVEF. https://t.co/z6xiOH5Acz @JavedButler1 https://t.co/zUM5oo841O
-
-
Mashup Score: 2Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis - 7 month(s) ago
AbstractAims. Identifying patients with cardiac sarcoidosis (CS) who are at an increased risk of sudden cardiac death (SCD) poses a clinical challenge. We sough
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 13Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors: A DCCSS LATER Study - 8 month(s) ago
Abstract Background Childhood cancer survivors (CCS) are at risk for cardiotoxicity. Objectives We sought to assess how cardiac dysfunction measurements in CCS overlap and are differentially influe…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Revascularization for Ischemic Ventricular Dysfunction - American College of Cardiology - 9 month(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors∗ : - 9 month(s) ago
Corresponding Author
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 9Long-Term Outcomes of Pregnancy After Peripartum Cardiomyopathy - American College of Cardiology - 10 month(s) ago
Melinda Davis, MD, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Q: What are the long-term outcomes among women w/ subsequent pregnancy (SSP) after peripartum cardiomyopathy (PPCM)? A: Subsequent pregnancies after PPCM are associated w/ short- & long-term adverse events, even among women w/ initial #LVEF recovery. 🔗 https://t.co/m3mFrzwwWV https://t.co/xSbcazIv2B
-
-
Mashup Score: 1Earlier Detection of Cardiac Dysfunction Possible for Young Adult Cancer Survivors - 11 month(s) ago
A case for monitoring global longitudinal strain despite normal LVEF
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Left Bundle Branch Area Pacing: A New Alternative to Biventricular Pacing? - American College of Cardiology - 12 month(s) ago
Left bundle branch area pacing (LBBAP) is a safe and effective alternative to biventricular pacing (BVP) for patients undergoing cardiac resynchronization therapy (CRT) to treat reduced left ventricular ejection fraction (LVEF), heart failure and wide QRS or expected frequent ventricular pacing, according to a late-breaking clinical trial presented during Heart Rhythm 2023 and simultaneously…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
A new analysis of the STEP-HFpEF trial in #JACC shows that the benefits of semaglutide in patients w/ the obesity phenotype of #HFpEF don’t seem to be impacted by #LVEF. @ToddNeale covers the findings in @TCTMD: https://t.co/85jn7B5NAJ